サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433344

血行動態モニタリングの世界市場：2023-2030年

Global Hemodynamic Monitoring Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 175 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血行動態モニタリングの世界市場：2023-2030年
出版日: 2023年12月15日
発行: Orion Market Research
ページ情報: 英文 175 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血行動態モニタリング市場は、予測期間（2023-2030年）にCAGR 5.2％で成長すると予測されています。市場成長の背景には、医療支出の増加があります。医療インフラとテクノロジーへの投資の増加は、血行動態モニタリング業界を前進させるのに役立ちます。MDPI（Publisher of Open Access Journals）が2023年2月に発表したレポートによると、血行動態モニタリングは大きな発展を遂げていますが、診断や治療に利用できるデータ量が限られているため、まだいくつかの問題があります。さらに、何をもって健康な血圧（BP）範囲とみなすかについては議論があり、最近の知見では、平均動脈圧（MAP）閾値65mmHgを低血圧状態を予防するための絶対的最低値とみなすべきであるとされています。しかし、これは輸液/血管圧迫療法プロトコールにおける個人別の血圧閾値を目指す動きと矛盾します。さらに、敗血症の症例では微小循環機能が解離していることが判明していますが、微小循環のモニタリングはまだ面倒な作業です。さらに、低急性期における悪化の早期発見が必要であり、病棟のモニタリングが不十分であったために手術後30日以内に死亡した患者が世界で毎年420万例もあります。既存の病棟測定では、いまだに90％の誤報率があります。このことは、限られた情報で血行動態が不安定な患者を管理する必要性をさらに強調しています。

セグメント別の展望

非侵襲的モニタリングシステムが世界の血行動態モニタリング市場で大きなシェアを占めると予想される

システムの中でも、非侵襲的モニタリングシステムのサブセグメントが世界の血行動態モニタリング市場でかなりのシェアを占めると予測されています。このセグメントの成長は、世界中で使用されている技術と方法に起因しています。非侵襲的モニタリングシステムには、インピーダンス心電計、心エコー検査、脈拍輪郭解析などのさまざまな技術が含まれます。それぞれの方法には利点と欠点があります。例えば、これらの方法は使いやすく患者の苦痛を軽減しますが、特に心血管系の機能が低下している場合には、サーモダイリューションのような侵襲的な方法ほど正確ではありません。米国国立衛生研究所（National Institute of Health（gov.））によると、2021年10月、非侵襲的血行動態モニタリング技術の精度を評価するため、84人の心不全患者を対象とした研究が行われました。患者の大半はNYHA IIIおよびIVで、平均駆出率は27％でした。その結果、非侵襲的な心拍出量の測定は熱希釈法ほど正確ではなく、過大評価であることが判明しました。この結果は、心拍出量が減少し末梢血管抵抗が増加した場合、非侵襲的血行動態モニタリング法の精度が低下することを示した他の研究と一致しています。これらの知見は、集中治療室に入院した重篤な状態の患者の測定に不正確さがある理由を説明するのに役立つかもしれません。

地域別の展望

世界の血行動態モニタリング市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。中でも北米は、慢性疾患を患う米国の高齢化人口の増加に加え、ICUや救急治療室での血行動態モニタリングシステムの使用増加により、北米市場の成長を牽引しているため、世界全体で大きなシェアを占めると予想されます。

アジア太平洋地域は血行動態モニタリング世界市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、同地域全体のアルゴリズムとデータ分析における進歩の高まりに起因しています。Mostcare Upが強調したようなアルゴリズムの革新は、血行動態モニタリングにおけるデータ分析の価値を実証しています。このパターンは、より複雑で精密な分析方法に重点を置きながら、今後も続くと予想されます。例えば、2023年4月、Vygon India社は、クリティカルケア医学会（ISCCM）のシンポジウムの中で、北インドで先進血行動態モニタリングシステムMostcare Upを発売しました。Mostcare Upは低侵襲の動脈圧モニターで、圧力記録分析法（PRAM）に基づく特許取得済みのアルゴリズムを搭載しています。このモニターは、わずかな血行動態の変動さえもリアルタイムで、しかも拍動ごとに監視できる唯一のモニターです。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Argon Medical Devices, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Baxter International, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Change Healthcare
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 血行動態モニタリングの世界市場：システム別
    • 低侵襲的モニタリングシステム
    • 侵襲的モニタリングシステム
    • 非侵襲的モニタリングシステム
    • その他（総合モニタリングシステム、モニタリング機器・消耗品）
  • 血行動態モニタリングの世界市場：製品別
    • 消耗品
    • モニター
  • 血行動態モニタリングの世界市場：エンドユーザー別
    • 病院
    • 診療所および外来医療センター
    • 外来医療センター
    • 在宅医療
    • その他（研究・学術機関、製薬・バイオテクノロジー企業）

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Deltex Medical Ltd.
  • Drager
  • Edwards Lifesciences Corp.
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hemo Sapiens Inc.
  • ICU Medical, Inc
  • Masimo Corp.
  • Nihon Kohden
  • Nonin Medical, Inc.
  • Philips International B.V.
  • Schwarzer Cardiotek GmbH
  • Tensys Medical Inc.
  • Terumo Group
図表

LIST OF TABLES

  • 1. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 2. GLOBAL MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NON-INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHERS HEMODYNAMIC MONITORING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 7. GLOBAL HEMODYNAMIC DISPOSABLES MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL HEMODYNAMIC MONITORS MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL HEMODYNAMIC MONITORING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL HEMODYNAMIC MONITORING FOR CLINICS AND AMBULATORY CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL HEMODYNAMIC MONITORING FOR AMBULATORY CARE CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL HEMODYNAMIC MONITORING FOR HOME CARE SETTINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL HEMODYNAMIC MONITORING FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT,2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 20. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 22. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 23. EUROPEAN HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY SYSTEM, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY PRODUCT ,2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY SYSTEM, 2022 VS 2030 (%)
  • 2. GLOBAL MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NON-INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 7. GLOBAL HEMODYNAMIC DISPOSABLES MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL HEMODYNAMIC MONITORS MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 10. GLOBAL HEMODYNAMIC MONITORING FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL HEMODYNAMIC MONITORING FOR CLINICS AND AMBULATORY CARE CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL HEMODYNAMIC MONITORING FOR AMBULATORY CARE CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL HEMODYNAMIC MONITORING FOR HOME CARE SETTINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL HEMODYNAMIC MONITORING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL HEMODYNAMIC MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD HEMODYNAMIC MONITORING MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027945

Global Hemodynamic Monitoring Market Size, Share & Trends Analysis Report by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems, and others), by Product (Disposables and Monitors), and by End-User (Hospitals, Clinics & Ambulatory Care Centers, Ambulatory Care Centers, Home Care Settings, and Others), Forecast Period (2023-2030)

The global hemodynamic monitoring market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market's growth is attributed to the increasing healthcare expenditure. Growing investments in healthcare infrastructure and technologies help to propel the hemodynamic monitoring industry forward. According to the MDPI (Publisher of Open Access Journals), published a report in February 2023, which states that hemodynamic monitoring has seen a great deal of development, though there are still some issues owing to the limited amount of data available for diagnosis and treatment. Furthermore, there is some debate over what is considered a "healthy" blood pressure (BP) range, and recent findings suggest that a 65-mmHg mean arterial pressure (MAP) threshold should be regarded as an absolute minimum to prevent hypotensive conditions. However, this contradicts the movement towards personalized BP thresholds in fluid/vasopressor therapy protocols. Additionally, microcirculatory function has been found to be dissociated in cases of sepsis, though monitoring the microcirculation is still a tedious process. Furthermore, there is a need for earlier detection of deterioration in low-acuity settings, with 4.2 million cases of patient mortality within 30 days after surgery globally each year owing to insufficient ward monitoring. Existing ward measurements still have a false alarm rate of 90%. This further emphasizes the need for managing hemodynamically unstable patients with limited information.

Segmental Outlook

The global hemodynamic monitoring market is segmented based on the system, product, and end-user. Based on the system, the market is sub-segmented into minimally invasive monitoring systems, invasive monitoring systems, non-invasive monitoring systems, and others. Based on the product, the market is sub-segmented into disposables and monitors. Further, based on the end-user, the market is sub-segmented into hospitals, clinics & ambulatory care centers, ambulatory care centers, home care settings, and others. Among the product, monitors sub-segment is expected to capture a significant portion of the market share. This is attributed to the increasing investment by major manufacturers in developing patient-centric care and releasing technologically improved products to market is driving the demand for hemodynamic monitors.

The Non-invasive Monitoring Systems Sub-Segment is Anticipated to Hold a Considerable Share of the global Hemodynamic Monitoring Market

Among the system, the non-invasive monitoring systems sub-segment is expected to hold a considerable share of the global hemodynamic monitoring market. The segmental growth is attributed to technology and methods used across the globe. Non-invasive monitoring systems encompass various technologies such as impedance cardiograph, echocardiography, and pulse contour analysis. Each method has advantages and disadvantages. For instance, they offer ease of use and reduced patient distress, cannot be as precise as invasive methods like thermodilution, particularly in cases of impaired cardiovascular function. According to the National Institute of Health (gov.), in October 2021, a study of 84 heart failure patients was conducted to assess the accuracy of non-invasive hemodynamic monitoring techniques. The majority of patients were NYHA III and IV with a mean ejection fraction of 27%. The results showed that the non-invasive measurements of cardiac output were not as precise as the thermodilution method, that was found to be overestimating. This result is consistent with other studies which have shown that non-invasive hemodynamic monitoring methods are less accurate in cases of decreased cardiac output and increased peripheral vascular resistance. These insights might help explain why there is inaccuracy in measurements of patients in critical condition admitted in intensive care units.

Regional Outlook

The global hemodynamic monitoring market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increasing aging population in the US suffering from chronic diseases, in addition to the increased usage of hemodynamic monitoring systems in ICUs and emergency rooms, are driving North American market growth.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Hemodynamic Monitoring Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising advancements in algorithms and data analytics across the region. Algorithm innovations, such as individuals highlighted by Mostcare Up, demonstrate the value of data analytics in hemodynamic monitoring. The pattern is expected to continue, with an emphasis on more complex and precise analytical methods. For instance, in April 2023, Vygon India, launched advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium. Mostcare Up is a minimally invasive arterial pressure monitor that is powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor capable of monitoring even minor hemodynamic variations in real time and from beat to beat.

Market Players Outlook

The major companies serving the global hemodynamic monitoring market include Deltex Medical Ltd., Drager, Edwards Lifesciences Corp., GE HealthCare Technologies Inc., Getinge AB and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Sensydia, launched Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). As part of its Breakthrough Device Designation, the FDA intends to work closely with Sensydia to expedite CPS development and prioritize the assessment of subsequent regulatory submissions.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global hemodynamic monitoring market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Argon Medical Devices, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
    • 3.2.5. Baxter International, Inc.
    • 3.2.6. Overview
    • 3.2.7. Financial Analysis
    • 3.2.8. SWOT Analysis
    • 3.2.9. Recent Developments
  • 3.3. Change Healthcare
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Hemodynamic Monitoring Market by System
    • 4.1.1. Minimally Invasive Monitoring Systems
    • 4.1.2. Invasive Monitoring Systems
    • 4.1.3. Non-invasive Monitoring Systems
    • 4.1.4. Others (Total Monitoring Systems, and Monitoring Devices & Consumables)
  • 4.2. Global Hemodynamic Monitoring Market by Product
    • 4.2.1. Disposables
    • 4.2.2. Monitors
  • 4.3. Global Hemodynamic Monitoring Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Clinics and Ambulatory Care Centers
    • 4.3.3. Ambulatory Care Centers
    • 4.3.4. Home Care Settings
    • 4.3.5. Others (Research & Academic Institutes, and Pharmaceutical & Biotechnology Companies)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Deltex Medical Ltd.
  • 6.2. Drager
  • 6.3. Edwards Lifesciences Corp.
  • 6.4. GE HealthCare Technologies Inc.
  • 6.5. Getinge AB
  • 6.6. Hemo Sapiens Inc.
  • 6.7. ICU Medical, Inc
  • 6.8. Masimo Corp.
  • 6.9. Nihon Kohden
  • 6.10. Nonin Medical, Inc.
  • 6.11. Philips International B.V.
  • 6.12. Schwarzer Cardiotek GmbH
  • 6.13. Tensys Medical Inc.
  • 6.14. Terumo Group